
Crispr Stem & Therapeutics (CST) Israeli Company
Crispr Stem & Therapeutics (CST) is developing a patented cardio-protective CRISPR-based stem cell protocol to restrict the damage to the heart following acute heart attack and chronic heart failure.
Health Tech & Life Sciences
Alternatives
No alternatives listed yet.
Suggest an Alternative
Office Locations
Petah Tikva, Israel
References
[1]
finder.startupnationcentral.org
- https://finder.startupnationcentral.org/company_page/crispr-stem-therapeutics-cst
External links are provided for reference and verification purposes.